These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18447621)

  • 41. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
    Sekimukai H; Iwata-Yoshikawa N; Fukushi S; Tani H; Kataoka M; Suzuki T; Hasegawa H; Niikura K; Arai K; Nagata N
    Microbiol Immunol; 2020 Jan; 64(1):33-51. PubMed ID: 31692019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.
    Williams JV; Tollefson SJ; Johnson JE; Crowe JE
    J Virol; 2005 Sep; 79(17):10944-51. PubMed ID: 16103146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication.
    Mossel EC; Huang C; Narayanan K; Makino S; Tesh RB; Peters CJ
    J Virol; 2005 Mar; 79(6):3846-50. PubMed ID: 15731278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
    Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
    Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle.
    Li GM; Li YG; Yamate M; Li SM; Ikuta K
    Microbes Infect; 2007 Jan; 9(1):96-102. PubMed ID: 17194611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.
    Akerström S; Mirazimi A; Tan YJ
    Antiviral Res; 2007 Mar; 73(3):219-27. PubMed ID: 17112601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.
    Fukushi S; Mizutani T; Saijo M; Kurane I; Taguchi F; Tashiro M; Morikawa S
    J Med Virol; 2006 Dec; 78(12):1509-12. PubMed ID: 17063504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal transduction in SARS-CoV-infected cells.
    Mizutani T
    Ann N Y Acad Sci; 2007 Apr; 1102(1):86-95. PubMed ID: 17470913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
    Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
    World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication.
    Li YQ; Li ZL; Zhao WJ; Wen RX; Meng QW; Zeng Y
    Eur J Med Chem; 2006 Sep; 41(9):1084-9. PubMed ID: 16875760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).
    Wang S; Sakhatskyy P; Chou TH; Lu S
    J Immunol Methods; 2005 Jun; 301(1-2):21-30. PubMed ID: 15894326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.
    Cameron MJ; Kelvin AA; Leon AJ; Cameron CM; Ran L; Xu L; Chu YK; Danesh A; Fang Y; Li Q; Anderson A; Couch RC; Paquette SG; Fomukong NG; Kistner O; Lauchart M; Rowe T; Harrod KS; Jonsson CB; Kelvin DJ
    PLoS One; 2012; 7(9):e45842. PubMed ID: 23029269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
    Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
    Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Species-specific transcriptomic changes upon respiratory syncytial virus infection in cotton rats.
    Strickland BA; Rajagopala SV; Kamali A; Shilts MH; Pakala SB; Boukhvalova MS; Yooseph S; Blanco JCG; Das SR
    Sci Rep; 2022 Oct; 12(1):16579. PubMed ID: 36195733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth kinetics of SARS-coronavirus in Vero E6 cells.
    Keyaerts E; Vijgen L; Maes P; Neyts J; Van Ranst M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1147-51. PubMed ID: 15752773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.